Effects of stem cell therapy on left ventricular remodeling after acute myocardial infarction: A meta-analysis

Clinical Cardiology

Volumn 33, Issue 5, 2010, Pages 296-302

  Sun, Lan ^a   Zhang, Tiantai ^a   Lan, Xi ^a   Du, Guanhua ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; BONE MARROW CELL; CLINICAL ASSESSMENT; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DOUBLE BLIND PROCEDURE; EMBASE; FOLLOW UP; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HUMAN; INTRACORONARY INFUSION; MAJOR CLINICAL STUDY; MEDLINE; META ANALYSIS; MUSCLE CELL; RANDOMIZED CONTROLLED TRIAL; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 77953142190     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Adams JE III, Sicard GA, Allen BT, et al. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med. 1994;330(10):670-674.
2. Stewart S, MacIntyre K, Capewell S, et al. Heart failure and the aging population: an increasing burden in the 21st century? Heart. 2003;89(1):49-53.
3. Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl JMed. 2006;355(12):1199-1209.
4. Strauer BE, Kornowski R. Stem cell therapy in perspective. Circulation. 2003;107(7):929-934.
5. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410(6829):701-705.
6. Wollert KC, Drexler H. Clinical applications of stem cells for the heart. Circ Res. 2005;96(2):151-163.
7. Martin-Rendon E, Brunskill SJ, Hyde CJ, et al. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J. 2008;29(15):1807-1818.
8. Singh S, Arora R, Handa K, et al. Stem cells improve left ventricular function in acute myocardial infarction. Clin Cardiol. 2009;32(4):176-180.
9. Zhang S, Sun A, Xu D, et al. Impact of timing on efficacy and safety of intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials. Clin Cardiol. 2009;32(8): 458-466.
10. Zhang SN, Sun AJ, Ge JB, et al. Intracoronary autologous bone marrow stem cells transfer for patients with acute myocardial infarction: a meta-analysis of randomised controlled trials. Int J Cardiol. 2009;136(2):178-185.
11. Martin-Rendon E, Brunskill S, Dorée C, et al. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2008;8:CD006536. Available at: http://www2.cochrane.org/ reviews/en/protocol- 0F48175F82E26AA201CA3F302204ADA7. html. Accessed December 25, 2009.
12. Kang S, Yang YJ, Li CJ, et al. Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials. Coron Artery Dis. 2008;19(5):327-335.
13. Hristov M, Heussen N, Schober A, et al. Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis. J Cell Mol Med. 2006;10(3):727-733.
14. Lipinski MJ, Biondi-Zoccai GG, Abbate A, et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol. 2007;50(18):1761-1767.
15. Udelson JE, Konstam MA. Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction. J Card Fail. 2002;8(suppl 6): S465-S471.
16. Moher D, Pham B, Jones A, et al. Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses? Lancet. 1998;352(9128):609-613.
17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
18. Immunosuppression: 2004 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1994-2003. Ann Arbor, MI: HHS/HRSA/OSP/DOT and UNOS, 2004. Available at: http://www.ustransplant.org/annual-reports/archives/2004/ Chapter-II-AR-CD.htm. Accessed December 25, 2009.
19. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
20. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634.
21. Schächinger V, Assmus B, Erbs S, et al; REPAIR-AMI Investigators. Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial infarction (REPAIR-AMI) trial. Eur J Heart Fail. 2009;11(10): 973-979.
22. Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl JMed. 2006;355(12):1199-1209.
23. Li ZQ, Zhang M, Jing YZ, et al. The clinical study of autologous peripheral blood stemcell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI). Int J Cardiol. 2007;115(1):52-56.
24. Meyer GP, Wollert KC, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' followup data from the randomized, controlled BOOST (bone marrow transfer to enhance ST-elevation infarct regeneration) trial. Circulation. 2006;113(10):1287-1294.
25. Janssens S, Dubois C, Bogaert J, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet. 2006;367(9505):113-121.
26. Bartunek J, Vanderheyden M, Vandekerckhove B, et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recentmyocardial infarction: feasibility and safety. Circulation. 2005;112(9 Suppl):I178-183.
27. Kang HJ, Lee HY, Na SH, et al. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation. 2006;114(1 Suppl):I145-151.
28. Meluzín J, Mayer J, Groch L, et al. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. Am Heart J. 2006;152(5):975.
29. Huikuri HV, Kervinen K, Niemelä M, et al. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur Heart J. 2008;29(22): 2723-2732.
30. Choi JH, Choi J, Lee WS, et al. Lack of additional benefit of intracoronary transplantation of autologous peripheral blood stem cell in patients with acute myocardial infarction. Circ J. 2007;71(4):486-494.
31. Suárez de Lezo J, Herrera C, Pan M, et al. Regenerative therapy in patients with a revascularized acute anterior myocardial infarction and depressed ventricular function. Rev Esp Cardiol. 2007;60(4):357-365.
32. Lunde K, Solheim S, Forfang K, et al. Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up. J Am Coll Cardiol. 2008;51(6):674-676.
33. Agbulut O, Vandervelde S, Al Attar N, et al. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium. J Am Coll Cardiol. 2004;44(2):458-463.
34. Balsam LB, Wagers AJ, Christensen JL, et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemicmyocardium. Nature. 2004;428(6983):668-673.
35. Kamihata H, Matsubara H, Nishiue T, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation. 2001;104(9):1046-1052.
36. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360(9331):427-435.
37. Ziegelhoeffer T, Fernandez B, Kostin S, et al. Bone marrow derived cells do not incorporate into the adult growing vasculature. Circ Res. 2004;94(2):230-238.
38. Kinnaird T, Stabile E, Burnett MS, et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res. 2004;94(5):678-685.
39. Heil M, Ziegelhoeffer T, Mees B, et al. A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware. Circ Res. 2004;94(5): 573-574.
40. Dai W, Hale SL, Martin BJ, et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation. 2005;112(2):214-223.